TR200202165T2 - Matris metaloproteinaz inhibitörleri olarak kullanışlı olan hidroksamik asit bileşikleri - Google Patents
Matris metaloproteinaz inhibitörleri olarak kullanışlı olan hidroksamik asit bileşikleriInfo
- Publication number
- TR200202165T2 TR200202165T2 TR2002/02165T TR200202165T TR200202165T2 TR 200202165 T2 TR200202165 T2 TR 200202165T2 TR 2002/02165 T TR2002/02165 T TR 2002/02165T TR 200202165 T TR200202165 T TR 200202165T TR 200202165 T2 TR200202165 T2 TR 200202165T2
- Authority
- TR
- Turkey
- Prior art keywords
- matrix metalloproteinase
- compounds
- acid compounds
- compounds useful
- hydroxamic acid
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 title 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 title 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000025865 Ulcer Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 231100000397 ulcer Toxicity 0.000 abstract 2
- 206010002091 Anaesthesia Diseases 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010061217 Infestation Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 206010064996 Ulcerative keratitis Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000037005 anaesthesia Effects 0.000 abstract 1
- 208000007474 aortic aneurysm Diseases 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 201000007717 corneal ulcer Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Formül (I) bilesikleri hayvanlarda matris metaloproteinaz enzimlerinin inhibe edilmesinde yararlidir ve baglayici dokularin parcalanmasindan kaynaklanan hastaliklari önler ve tedavi eder. Ayrica bu tip bilesiklerin, bunlari içeren farmasötik bilesimlerin hazirlanmasi için yöntemler ve çoklu skleroz, ateroskleroz plak parçalanmasi, restenoz, aort anevrizmasi, kalp rahatsizligi, periodontal hastalik, kornea ülseri, yaniklar, decubital ülserler, kronik ülserler veya yaralar, kanser metastazi, tümör anjiojenezi, osteoporoz, römatoid veya osteoartrit, böbrek hastaligi, sol ventiküler büyüme veya dokularin lökosit istilasina bagli diger oto-bagisiklik veya iltihap hastaliklari dahil matris metaloproteinazlarin yer aldigi hastaliklarin tedavisinde kullanilmasi tarif edilmektedir.(formül var)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/021884 WO2001012592A2 (en) | 1999-08-18 | 2000-08-10 | Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200202165T2 true TR200202165T2 (tr) | 2002-11-21 |
Family
ID=21741670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2002/02165T TR200202165T2 (tr) | 2000-08-10 | 2000-08-10 | Matris metaloproteinaz inhibitörleri olarak kullanışlı olan hidroksamik asit bileşikleri |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR200202165T2 (tr) |
-
2000
- 2000-08-10 TR TR2002/02165T patent/TR200202165T2/tr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200202163T2 (tr) | Matris metaloproteinaz inhibitörleri olarak kullanışlı olan hidroksamik asit bileşikleri | |
| US7879366B2 (en) | Halogenated composition, method for preparing same and uses thereof | |
| CY1109328T1 (el) | Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου | |
| SE0101387D0 (sv) | Novel compounds | |
| FI971412A0 (fi) | Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä | |
| DE60329316D1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
| NO984120L (no) | Triarylforbindelser | |
| MEP10408A (en) | Platinum derivative pharmaceutical formulations | |
| CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
| DE60322425D1 (de) | Antikrebszubereitung enthaltend dmxaa | |
| CY1108992T1 (el) | Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας | |
| BRPI0410979A (pt) | composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia | |
| DE602007008385D1 (de) | Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris | |
| BR9815596A (pt) | Composto, composição farmacêutica, método de tratamento de doenças inflamatórias e método de tratamento de condição ou doença mediada por mmps e/ou tnf e/ou agrecanase | |
| MX2023010827A (es) | Derivados de pirazolopiridina y sus usos. | |
| DE602006016799D1 (de) | NEUE, HYALURONSÄURE ODER HYALURONSàURE DERIVATE UND COLLAGENASE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR TOPISCHEN BEHANDLUNG VON WUNDEN, VERBRENNUNGEN UND GESCHWÜREN | |
| PT1282628E (pt) | Triaminas do acido n-(2-pirimidinil)(tio)fosforico processo para a sua preparacao e sua utilizacao como agente para a regulacao ou inibicao da hidrolise enzimatica da ureia | |
| AR037766A1 (es) | Compuestos triaromaticos analogos de la vitamina d, su utilizacion, composiciones farmaceuticas y cosmeticas que los comprenden y utilizacion cosmetica de dichas composiciones cosmeticas | |
| AR032553A1 (es) | Derivados de alfa-amino-n-hidroxi-acetamida. | |
| NO20070250L (no) | S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor | |
| BR0317834A (pt) | Diamidas de ácido pirimidin-4,6-dicarboxìlico como inibidores mmp 13 seletivos | |
| HRP20040421B1 (hr) | INHIBICIJA VIRUSA n-DOKOZANOLOM | |
| SE0301884D0 (sv) | New use III | |
| SE0301885D0 (sv) | New use IV | |
| BR0307039A (pt) | Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias |